Research Article| Volume 162, ISSUE 2, P114-119, January 15, 1999

Download started.


Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia


      The permanent middle cerebral artery occlusion (PMCAO) model was used to investigate the cerebroprotective effects of the synthetic cannabinoid, dexanabinol (HU-211). Dexanabinol is a noncompetitive N-methyl-d-aspartate antagonist, with antioxidant and anti-TNFα properties. Twenty hypertensive rats were subjected to PMCAO. Eight were given 4 mg/kg dexanabinol, i.v., 1 h after PMCAO, eight received vehicle and four were not injected. Five rats underwent sham surgery. Infarct volumes were assessed, as well as TNFα concentrations and NOS activity in brain homogenates. Dexanabinol significantly decreased infarct volumes. It also significantly lowered TNFα levels in the ipsilateral hemisphere although not to the level of sham operated rats. No effect could be demonstrated on NOS activity. In conclusion, dexanabinol may be a pluripotent cerebroprotective agent.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Arvin B
        • Neville LF
        • Barone FC
        • Feuerstein GZ
        The role of inflammation and cytokines in brain injury.
        Neurosci Biobehav Rev. 1996; 20: 445-452
        • Barone FC
        • Arvin B
        • White RF
        • Miller A
        • Webb CL
        • Willette RN
        • Lysko PG
        • Feuerstein GZ
        Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.
        Stroke. 1997; 28: 1233-1244
        • Belayev L
        • Bar Joseph A
        • Adamchik J
        • Biegon A
        HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats.
        Mol Chem Neuropathol. 1995; 25: 19-33
        • Biegon A
        Neuroprotective activity of HU-211, a novel nonpsychotropic synthetic cannabinoid.
        Ann NY Acad Sci. 1995; 765: 314
        • Biegon A
        • Knoller N
        • Ehrenfreund N
        • Brewster M
        Pharmacokinetics of dexanabinol: effect of head trauma on drug disposition in patients.
        J Neurotrauma. 1997; 17: 758
        • Brewster M
        • Pop E
        • Foltz R
        • Reuschel S
        • Griffin W
        • Amselem S
        • Biegon A
        Clinical pharmacokinetics of escalating i.v. doses of dexanabinol (HU-211), a neuroprotectant agent, in normal volunteers.
        Int J Clin Pharmacol. 1997; 35: 361-365
        • Bruce AJ
        • Boling W
        • Kindy MS
        • Peschon J
        • Kraemer PJ
        • Carpenter MK
        • Holtsberg FW
        • Mattson MP
        Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors.
        Nature Med. 1997; 7: 788-794
        • Choi DW
        Methods for antagonizing glutamate neurotoxicity.
        Cerebrovasc Brain Metab Rev. 1990; 2: 105-147
        • Dalkara T
        • Moskowitz MA
        Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischaemia.
        Int Rev Neurobiol. 1997; 40: 319-336
        • Eshhar N
        • Striem S
        • Kohen R
        • Tirosh O
        • Biegon A
        Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist.
        Eur J Pharmacol. 1995; 283: 19-29
        • Feigenbaum JJ
        • Bergmann F
        • Richmond SA
        • Mechoulam R
        • Nadler V
        • Kloog Y
        • Sokolovsky M
        Nonpsychotropic cannabinoid acts as a functional N-methyl-d-aspartate receptor blocker.
        Proc Natl Acad Sci USA. 1989; 86: 9584-9587
        • Feuerstein GZ
        • Liu T
        • Barone FC
        Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha.
        Cerebrovasc Brain Metab Rev. 1994; 6: 341-360
        • Gallily R
        • Yamin A
        • Waksmann Y
        • Ovadia H
        • Weidenfeld J
        • Bar-Joseph A
        • Biegon A
        • Mechulam R
        • Shohami E
        Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.
        J Pharmacol Exp Ther. 1997; 283: 918-924
        • MacManus JP
        • Linnik MD
        Gene expression induced by cerebral ischemia: an apoptotic perspective.
        J Cereb Blood Flow Metab. 1997; 17: 815-832
        • Margaill I
        • Allix M
        • Boulu RG
        • Plotkine M
        Dose- and time-dependence of l-NAME neuroprotection in transient focal cerebral ischaemia in rats.
        Br J Pharmacol. 1997; 120: 160-163
        • McCulloch J
        Glutamate receptor antagonists in cerebral ischaemia.
        J Neural Transm Suppl. 1994; 43: 71-79
        • Meistrell M
        • Botchinka G
        • Wang H
        • Di-Santo E
        • Cockroft K
        • Bloom O
        • Vishnubhakat J
        • Ghezzi P
        • Tracey K
        Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia.
        Shock. 1997; 8: 341-348
        • Nawashiro H
        • Martin D
        • Hallenbeck JM
        Inhibition of tumor necrosis factor and amelioration of brain infarction in mice.
        J Cereb Blood Flow Metab. 1997; 17: 229-232
        • Nawashiro H
        • Tasaki K
        • Ruetzler CA
        • Hallenbeck JM
        TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice.
        J Cereb Blood Flow Metab. 1997; 17: 483-490
        • Olesen SP
        • Moller A
        • Mordvintcev PI
        • Busse R
        • Mulsch A
        Regional measurements of NO formed in vivo during brain ischemia.
        Acta Neurol Scand. 1997; 95: 219-224
        • Sadoshima S
        • Nagao T
        • Okada Y
        • Fujii K
        • Ibayashi S
        • Fujishima M
        l-Arginine ameliorates recirculation and metabolic derangement in brain ischemia in hypertensive rats.
        Brain Res. 1997; 744: 246-252
        • Saito K
        • Suyama K
        • Nishida K
        • Sei Y
        • Basile AS
        Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain.
        Neurosci Lett. 1996; 206: 149-152
        • Samdani AF
        • Dawson TM
        • Dawson VL
        Nitric oxide synthase in models of focal ischemia.
        Stroke. 1997; 28: 1283-1288
        • Scherbel U
        • Rhagupathi R
        • Nakamura M
        • Saatman K
        • McIntosh TK
        Evaluation of neurobehavioral deficits in brain-injured tumor necrosis factor deficient mice after experimental brain injury.
        J Neurotrauma. 1997; 7: 781
        • Shohami E
        • Gallily R
        • Mechoulam R
        • Bass R
        • Ben Hur T
        Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.
        J Neuroimmunol. 1997; 72: 169-177
        • Shohami E
        • Novikov M
        • Bass R
        Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.
        Brain Res. 1995; 674: 55-62
        • Shohami E
        • Novikov M
        • Mechoulam R
        A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.
        J Neurotrauma. 1993; 10: 109-119
        • Wityk RJ
        • Stern BJ
        Ischemic stroke: today and tomorrow.
        Crit Care Med. 1994; 22: 1278-1293
        • Zhai QH
        • Futerll N
        • Chen FJ
        Gene expression of IL-10 in relationship to TNF alpha, IL-1beta, and IL-2 in the rat brain following middle cerebral artery occlusion.
        J Neurol Sci. 1997; 152: 1119-1124